Fujii, K., Yamamoto, Y., Mizutani, Y., Saito, K., & Seishima, M. (2020). <i>Indoleamine 2,3-Dioxygenase 2</i> Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation. MDPI AG.
シカゴスタイル引用形Fujii, Kento, Yasuko Yamamoto, Yoko Mizutani, Kuniaki Saito, , Mariko Seishima. <i>Indoleamine 2,3-Dioxygenase 2</i> Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation. MDPI AG, 2020.
MLA引用形式Fujii, Kento, et al. <i>Indoleamine 2,3-Dioxygenase 2</i> Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation. MDPI AG, 2020.
警告: この引用は必ずしも正確ではありません.